1,3,5-triaza-7-phosphaadamantane has been researched along with bortezomib in 1 studies
Studies (1,3,5-triaza-7-phosphaadamantane) | Trials (1,3,5-triaza-7-phosphaadamantane) | Recent Studies (post-2010) (1,3,5-triaza-7-phosphaadamantane) | Studies (bortezomib) | Trials (bortezomib) | Recent Studies (post-2010) (bortezomib) |
---|---|---|---|---|---|
44 | 0 | 33 | 6,868 | 860 | 4,753 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alberti, P; Avezza, F; Bravin, A; Cavaletti, G; Ceresa, C; Gandin, V; Monfrini, M; Nicolini, G; Pellei, M; Santini, C; Semperboni, S | 1 |
1 other study(ies) available for 1,3,5-triaza-7-phosphaadamantane and bortezomib
Article | Year |
---|---|
Evaluation of the Profile and Mechanism of Neurotoxicity of Water-Soluble [Cu(P)
Topics: Action Potentials; Adamantane; Animals; Antineoplastic Agents; Bortezomib; Carcinoma; Cell Line, Tumor; Cells, Cultured; Cisplatin; Copper; Dose-Response Relationship, Drug; Embryo, Mammalian; Female; Ganglia, Spinal; Gold; Humans; Mice; Mice, Inbred C57BL; Neuronal Outgrowth; Neurons; Organophosphorus Compounds; Peripheral Nerves; Polymerization; Proteasome Endopeptidase Complex; Rats; Rats, Sprague-Dawley; Tubulin | 2018 |